Imagine reaching for your arthritis supplement, a product meant to ease your pain, only to discover it could be silently poisoning you with lead. This alarming scenario is exactly what the FDA is warning about, and it’s more common than you might think. But here’s where it gets even more concerning: the supplement in question, Rheumacare capsules by Navafresh, has been found to contain lead levels up to 11,100 ppm—far exceeding safe limits. This isn’t just a minor oversight; it’s a serious health hazard that could lead to cognitive impairment, reproductive issues, and even life-threatening conditions like seizures or coma.
Handelnine Global Limited, the company behind Navafresh, has issued a recall for two specific lots of Rheumacare capsules: CAM040 and CALO79-N. These capsules, marketed as a combination of anti-inflammatory, analgesic, and disease-modifying drugs, were sold nationwide through the company’s website, www.navafresh.com. The FDA’s warning letter to Handelnine in November flagged several of their products as ‘unapproved new drugs,’ including Rheumacare, raising questions about the company’s manufacturing practices and product safety.
And this is the part most people miss: Lead exposure isn’t just about immediate symptoms. Prolonged exposure can silently wreak havoc on your body, leading to anemia, reduced fertility, and even miscarriage. For children, the risks are even more severe, as lead poisoning can impair cognitive development and cause irreversible damage. The FDA’s findings suggest that Rheumacare’s manufacturing process was flawed, putting consumers at unnecessary risk.
Handelnine has acknowledged one ‘adverse event complaint’ related to the recall and is notifying distributors and customers via email. If you’ve purchased these capsules, the company urges you to stop using them immediately, discard them, and request a refund. For more information, contact Ankit Mota at +1 422-223-0999 (5 a.m. to noon ET, Monday through Friday) or email legal@handelnine.com.
Here’s the controversial question: How did a product claiming to treat arthritis end up containing toxic levels of lead? Is this an isolated incident, or does it point to broader issues in supplement regulation? The FDA’s warning highlights the need for stricter oversight, but it also raises concerns about consumer trust in over-the-counter remedies. What do you think? Are supplements like Rheumacare being held to the same safety standards as prescription medications? Share your thoughts in the comments below—this is a conversation that needs to happen.
